Drug Discovery World: Developments in Concussion Therapies

Written By Holly Plante

The editor of Drug Discovery World, Reece Armstrong,  speaks to Michael Wyand, CEO  of Oxeia about the development of the company’s treatment for concussion (OXE103) and the current lack of effective therapies for #brain injuries.

https://www.ddw-online.com/qa-developments-in-concussion-therapies-29643-202405/

Holly Plante
Previous

Drug Discovery World: Neuroscience: Advances in research and opportunities ahead
Next

ACRM: Results of Research at the University of Kansas Medical Center